Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $2.31 Billion
- Q3 2024
A detailed history of Eco R1 Capital, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 11,890,843 shares of APLS stock, worth $396 Million. This represents 14.88% of its overall portfolio holdings.
Number of Shares
11,890,843
Previous 11,607,425
2.44%
Holding current value
$396 Million
Previous $445 Million
22.98%
% of portfolio
14.88%
Previous 15.74%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$519 Million0.08% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$370 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$193 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.4MShares$147 Million4.68% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.66B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...